NCT02959437 2025-10-21Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)Incyte CorporationPhase 1/2 Terminated70 enrolled 14 charts
NCT03291054 2024-06-11Epacadostat and Pembrolizumab in Patients With GISTColumbia UniversityPhase 2 Terminated1 enrolled 1 chart
NCT03823131 2023-05-09Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and EpacadostatUniversity of California, San FranciscoPhase 2 Terminated14 enrolled 12 charts
NCT03347123 2022-02-28A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)Incyte CorporationPhase 1/2 Terminated11 enrolled 12 charts
NCT03277352 2021-07-22INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Terminated10 enrolled 14 charts
NCT03361228 2020-05-21A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled 4 charts
NCT03348904 2019-06-13Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung CancerIncyte CorporationPhase 3 Terminated2 enrolled 6 charts